Long-term cardiovascular risk in survivors of hematologic malignancies: a meta-analysis
Siqing Liu, Shuran Liu, Yining Hu, Jiawen Deng, Guoli Sun, Xuexian Fang · 2026
Read Long-term cardiovascular risk in survivors of hematologic malignancies: a meta-analysis by Siqing Liu, Shuran Liu, Yining Hu, Jiawen Deng, Guoli Sun, Xuexian Fang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13540886.txt.
Description
Siqing Liu and five colleagues pool, in a 2026 meta-analysis, evidence on heart and vessel disease appearing long after treatment for blood cancers. Survival keeps improving, so late effects on the heart matter to a growing population.
Fifty studies with more than half a million participants were included. Leukaemia survivors faced well over double the overall cardiovascular risk of comparison groups, with heart failure risk about four times higher. Hodgkin and non-Hodgkin lymphoma survivors showed similar positive links. Treatment type mattered greatly: survivors treated with radiotherapy had roughly twice the cardiovascular risk of those treated with chemotherapy. The authors push targeted heart prevention for this group.
Catalog record
| CREATOR | Siqing Liu, Shuran Liu, Yining Hu, Jiawen Deng, Guoli Sun, Xuexian Fang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31627 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |